IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Prosight Management, LP

Q4 2017 Holdings

Filed 2018-02-13 | 29 holdings | $1.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Healthcare Company in(ACHC)COM00404A109$878.0K26,91686.7%
Allergan PLCSHSG0177J108$16.0K98,0001.6%
Macrogenics Inc(MGNX)COM556099109$11.5K607,6961.1%
Cidara Therapeutics IncCOM171757107$11.2K1,647,8791.1%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$9.5K678,7930.9%
Sabra Health Care REIT Inc(SBRA)COM78573L106$7.5K402,0570.7%
Centene Corp del(CNC)COM15135B101$7.2K71,0000.7%
Chimerix Inc(CMRXEUR)COM16934W106$6.8K1,478,5190.7%
Achaogen IncCOM004449104$6.1K570,9200.6%
Uniqure NV(QURE)SHSN90064101$5.6K284,7170.6%
Almost Family IncCOM020409108$5.0K90,5480.5%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$4.9K172,8970.5%
Quotient LTDSHSG73268107$4.6K932,5230.5%
Ignyta IncCOM451731103$4.6K171,3520.5%
Iovance Biotherapeutics Inc(IOVA)COM462260100$4.1K506,8520.4%
Endologix IncCOM29266S106$3.5K655,8150.3%
Radius Health IncCOM NEW750469207$3.5K110,0000.3%
Paratek Pharmaceuticals IncCOM699374302$3.2K178,4530.3%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$3.0K1,057,6900.3%
Nabriva Therapeutics PLCSHSG63637105$2.9K491,3950.3%
Clovis Oncology Inc(CLVSEUR)COM189464100$2.7K40,0000.3%
Bellicum Pharmaceuticals IncCOM079481107$2.5K301,3490.3%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$2.1K44,6000.2%
Dexcom Inc(DXCM)COM252131107$1.8K31,1980.2%
ON Assignment IncPutPUT682159958$1.7K25,7000.2%
Lipocine Inc NewCOM53630X104$1.3K373,1010.1%
Conformis Inc(CFMS)COM20717E101$952400,0000.1%
Novelion Therapeutics IncCOM NEW67001K202$925296,4880.1%
Adamas Pharmaceuticals Inc(ADMSEUR)COM00548A106$40712,0000.0%